Trial AMPlify Designs a Multi Language Clinical Trial Site for Vivet

Jonathan Eilberg • Aug 05, 2022

Trial AMPlify, a leading clinical trial digital advertising agency located in Boston, MA, designed and developed a multi-language website to promote a new Wilson's Disease gene therapy study across the US and Europe.

Multi language clinical trial website

Trial AMPlify, a division of Boston Web Partners, launches a new multi-language clinical trial website for Vivet Therapeutics to study a new gene therapy to address Wilson's Disease. The disease is caused by mutations in a gene called ATP7B. VTX-801.


The website design was developed on an easy to edit platform without the need for constant plugin maintenance or theme updates. Site is hosted on Amazon (AWS) servers to ensure fast page loading. 90% of the Top 10 global biopharma companies use AWS.


Unlike other web design agencies, Trial AMPlify is able to eliminate the concern over WordPress malware attacks, and GDPR plugin compliance issues.


SEO best practices were implemented to help the site to rank higher in Google searches over time. While SEO is taking hold, a Google Ads campaign was launched to help drive web visitor traffic to the site immediately to increase subject enrollment across the US and Europe.


>> Click here to view the site - www.gatewaytrialwilsondisease.com



 

Family of a clinical trial patient discussing a study

Joining a Clinical Trial: A Family Decision

By Jon Eilberg • 28 Apr, 2024
Trial AMPlify makes the case that a clinical trial is a family decision and that it may involve a spouse, sibling, or parent who is opposed to joining a study.
Clinical Trial Marketing

Clinical Trial Marketing Best Practices for 2024

By Jonathan Eilberg • 01 Jan, 2024
Clinical trial marketing is critical for building awareness, trust and credibility when announcing and promoting studies, but most sponsors skip this step.
Woman patient refusing to join a clinical trial

Why Patients Refuse to Join a Clinical Trial and What Sponsors Can Do About It.

By Jonathan Eilberg • 16 Dec, 2023
Trial AMPlify examines why people refuse to join clinical trials and the critical role patient recruitment firms play in increasing enrollment. Learn more
Clinical Trial Manager

Why So Many Patient Recruitment Campaigns Fail, and What Sponsors Can Do Differently to Improve Enrollment.

By Jonathan Eilberg • 04 Dec, 2023
Trial AMPlify examines why so many clinical trial patient recruitment campaigns fail and what can be done to help increase subject enrollment. Learn More
Patient Recruitment Agency

What is the Role of a Patient Recruitment Agency

By Jonathan Eilberg • 20 Nov, 2023
Trial AMPlify helps define what a patient recruitment agency does and the ways it can help sponsors and CRO's enroll qualified study subjects. Learn More
Clinical Trial Patient Recruitment Agency Team

The Definitive Clinical Trial Patient Recruitment Glossary of Terms

14 Nov, 2023
Trial AMPlify presents a list of clinical trial patient recruitment terms for when a definition might escape you. Print the document for quick reference.
Patient Recruitment Website Traffic Graph

Now is Not the Time to Push Biotech Firms to the Financial Limit

By Trial AMPlify • 05 May, 2023
Trial AMPlify, a leader in clinical trial patient recruitment makes a case to help biotech’s launch studies more quickly in these tough financial times.
Clinical Trial diversity and how we get there

Calls for More Diverse Infrastructure Upgrades to US Emergency Trials Framework | Trial AMPlify

By Jonathan Eilberg • 22 Mar, 2023
Trial AMPlify, a patient recruitment marketing agency based in Boston, relays ways US clinical trials can increase diverse patient enrollment.
Outsourcing Pharma Interview

Outsourcing Pharma Interview w/ Trial AMPlify's CEO Jon Eilberg

23 Feb, 2023
Trial AMPlify is featured in latest issue of Outsourcing Pharma
Clinical Trial Abandonment

Why Some Patients Abandon Clinical Trials Prematurely

By Jonathan Eilberg • 22 Feb, 2023
Trial AMPlify explores the reason why some patients leave clinical trials prematurely, and how this affects the outcome of the study data. Learn More.
More Posts
Share by: